GLW vs LXRX · P/E 101, rev $15.63B vs rev $21.8M
Corning Incorporated (GLW) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Corning Incorporated (GLW) is a electronic components company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported GLW revenue for 2025-12-31 was $15.63B. Net income was $1.60B. Revenue was up 19.1% from 2024-12-31 to 2025-12-31. GLW currently screens at market cap $44.76B and trailing P/E 100.5.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
GLW currently screens at market cap $44.76B and trailing P/E 100.5. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the GLW and LXRX stock pages for the full models.
Not investment advice.